Back
Protalix BioTherapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
56
PLX
Protalix BioTherapeutics
Last Price:
1.10
Seasonality Move:
27.19%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is moderately bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
Protalix BioTherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.09 | Buy |
| 20-day SMA: | 1.02 | Buy |
| 50-day SMA: | 1.04 | Buy |
| 200-day SMA: | 1.29 | Sell |
| 8-day EMA: | 1.09 | Buy |
| 20-day EMA: | 1.05 | Buy |
| 50-day EMA: | 1.05 | Buy |
| 200-day EMA: | 1.25 | Sell |
Protalix BioTherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 57.87 | Buy |
| Chaikin Money Flow: | -124332 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.94 - 1.08) | Buy |
| Bollinger Bands (100): | (1.01 - 1.19) | Sell |
Protalix BioTherapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.10 while PLX 8-day simple moving average is 1.09, which is a Buy signal.
- The stock price of PLX is 1.10 while Protalix BioTherapeutics 20-day SMA is 1.02, which makes it a Buy.
- Protalix BioTherapeutics 50-day simple moving average is 1.04 while PLX share price is 1.10, making it a Buy technically.
- PLX stock price is 1.10 and Protalix BioTherapeutics 200-day simple moving average is 1.29, creating a Sell signal.
PLX Technical Analysis vs Fundamental Analysis
Buy
56
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a Buy
The current Protalix BioTherapeutics [PLX] share price is $1.10. The Score for PLX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
80.9M
Price in USD:
1.10
Share Volume:
124.33K
Protalix BioTherapeutics 52-Week Range
52-Week High:
1.90
52-Week Low:
0.82
Buy
56
Protalix BioTherapeutics (PLX)
is a Buy
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?
The Protalix BioTherapeutics stock price is 1.10 USD today. -
Will PLX stock go up or go down?
Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protalix BioTherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is not overvalued.
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.10 while PLX 8-day exponential moving average is 1.09, which is a Buy signal.
- The stock price of PLX is 1.10 while Protalix BioTherapeutics 20-day EMA is 1.05, which makes it a Buy.
- Protalix BioTherapeutics 50-day exponential moving average is 1.05 while PLX share price is 1.10, making it a Buy technically.
- PLX stock price is 1.10 and Protalix BioTherapeutics 200-day simple moving average is 1.25, creating a Sell signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
- PLX Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Protalix BioTherapeutics is a Buy
- Protalix BioTherapeutics Relative Strength Index (RSI) is 57.87, which suggest Protalix BioTherapeutics is overbought
- The Bollinger Bands (25) for Protalix BioTherapeutics is (0.94 - 1.08), which suggest Protalix BioTherapeutics is a Sell
- The Bollinger Bands (100) for Protalix BioTherapeutics is (1.01 - 1.19), which suggest Protalix BioTherapeutics is a Sell
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.